Breaking News Instant updates and real-time market news.

CIEN

Ciena

$20.74

-0.715 (-3.33%)

, ACIA

Acacia Communications

$69.26

-1.41 (-2.00%)

15:31
12/01/16
12/01
15:31
12/01/16
15:31

Amazon cloud conference leaves William Blair bullish on networking components

Weighing in on Amazon's "re:Invent" cloud conference this week, William Blair says the company's continued data center investments and the wider growth in cloud computing are positives for networking component companies. BLAIR BULLISH ON NETWORKING: Offering his takeaway from major trends at re:Invent, William Blair analyst Dmitry Netis argued Thursday that Ciena (CIEN) is "well-positioned" to support Amazon's new Hawaii subsea cable, adding that Acacia (ACIA) is also a likely beneficiary of the company's network buildout. More generally, proliferation of optical networking equipment in the data center is a "long-term tailwind" to Finisar (FNSR), Lumentum (LITE), Oclaro (OCLR), Inphi (IPHI), MACOM (MTSI) and Applied Optoelectronics (AAOI), with Netis estimating a "massive opportunity for datacom optics vendors" as datacenter providers boost speeds and shift to server-side transceivers. Shifts toward custom-built routers, however, "presents a long-term threat" to routing incumbents Cisco (CSCO) and Juniper (JNPR), though the same trend will likely benefit off-the-shelf silicon and optical component vendors, Netis says, noting that Amazon counts Broadcom (AVGO), Marvell (MRVL), Cavium (CAVM) and Mellanox (MLNX) among its vendors.

CIEN

Ciena

$20.74

-0.715 (-3.33%)

ACIA

Acacia Communications

$69.26

-1.41 (-2.00%)

FNSR

Finisar

$33.23

-0.84 (-2.47%)

LITE

Lumentum

$40.10

-1.25 (-3.02%)

OCLR

Oclaro

$8.94

-0.2 (-2.19%)

IPHI

Inphi

$40.22

-4.95 (-10.96%)

MTSI

MACOM

$49.82

0.32 (0.65%)

AAOI

Applied Optoelectronics

$24.77

-0.27 (-1.08%)

CSCO

Cisco

$29.82

-0.01 (-0.03%)

JNPR

Juniper

$26.92

-0.62 (-2.25%)

AVGO

Broadcom

$170.49

-4.96 (-2.83%)

MRVL

Marvell

$14.34

-0.04 (-0.28%)

CAVM

Cavium

$57.03

-0.28 (-0.49%)

MLNX

Mellanox

$41.45

0.45 (1.10%)

  • 05

    Dec

  • 05

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 12

    Dec

  • 14

    Dec

  • 15

    Dec

CIEN Ciena
$20.74

-0.715 (-3.33%)

11/14/16
DBAB
11/14/16
UPGRADE
Target $27
DBAB
Buy
Ciena upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath upgraded Ciena to Buy and raised his price target for the shares to $27 from $20. The analyst says his proprietary analysis indicates "solid order trends" in 100G+ Optical at Hyperscale Clouds for Datacenter Interconnects and Sub-sea.
09/30/16
STFL
09/30/16
INITIATION
STFL
Hold
Ciena coverage resumed with a Hold at Stifel
Stifel analyst Patrick Newton resumed coverage of Ciena with a Neutral rating. He says that consensus estimates for the company adequately reflect its growth opportunities. Target $23.
10/06/16
MKMP
10/06/16
NO CHANGE
Target $28
MKMP
Buy
Ciena's Q4 orders are strong, says MKM Partners
MKM Partners analyst Michael Genovese said Ciena mid-quarter field checks suggest Q4 orders are strong with incremental order acceleration in the Subseas market in the US, Asia-Pacific, and in the US Metro market. Genovese believes investor gross margin fears are overblown and reiterates his Buy rating and a $28 price target.
09/06/16
NEED
09/06/16
NO CHANGE
Target $30
NEED
Buy
Needham more positive on Ciena business outlook
Needham analyst Alex Henderson has a more positive perspective on Ciena's shares and the company's business outlook following its earnings release. Given the accelerating demand, strengthening metro and more end-to-end with Flex Coherent, the analyst believes Ciena is "uniquely positioned for growth" with expanding margins. He reiterates a Buy rating and $30 price target on the shares.
ACIA Acacia Communications
$69.26

-1.41 (-2.00%)

11/11/16
NEED
11/11/16
NO CHANGE
Target $125
NEED
Buy
Acacia Communications beats estimates on 'robust demand,' says Needham
Needham analyst Alex Henderson notes that Acacia Communications sharply beat the original Q3 estimates and guided substantially above the original Q4 estimates which were in place before it positively pre-released. Further, the analyst points out that even after the increase in the estimates post the pre-release the actual results and guide were still better than the raised Street estimates. Henderson thinks the company is benefiting and demonstrating the strength of the multi-segment "Optical Super Cycle" in Metro Core, Data Comm/DCI and China. He reiterates a Buy rating and $125 price target on the shares.
11/11/16
WBLR
11/11/16
NO CHANGE
WBLR
Outperform
Acacia inexpensive relative to growth, says William Blair
William Blair analyst Dmitry Netis views Acacia Communications' Q3 results as solid with "strong" visibility and customer diversification. The company saw triple-digit year-over-year growth in the quarter and is on track to end the year at near-100% growth, Netis tells investors in a post-earnings research note. He views the stock as inexpensive relative to the growth and reiterates an Outperform rating on Acacia.
11/08/16
COWN
11/08/16
NO CHANGE
Target $99
COWN
Outperform
Acacia Communications price target raised to $99 from $90 at Cowen
Cowen analyst Paul Silverstein raised his price target on Acacia Communications to $99 from $90 as he believes the company remains strongly positioned to benefit from a strong optical upgrade cycle. The analyst said the upgrade cycle should drive impressive growth and operating profitability. He also believes investor concerns are misplaced with regards to revenue from ADVA Optical and ZTE, two of Acacia's largest customers. Silverstein reiterated his Outperform rating on Acacia Communications shares.
11/11/16
COWN
11/11/16
NO CHANGE
Target $115
COWN
Outperform
Acacia Communications price target raised to $115 from $99 at Cowen
Cowen analyst Paul Silverstein raised his price target on Acacia Communications to $115 from $99 as its Q3 results bolstered his investment outlook. The analyst believes the company will continue to show impressive growth driven by the 100G+ optical upgrade cycle. Silverstein reiterated his Outperform rating on Acacia Communications shares.
FNSR Finisar
$33.23

-0.84 (-2.47%)

11/28/16
11/28/16
UPGRADE
Target $42

Strong Buy
Finisar upgraded to Strong Buy ahead of results at Needham
As previously reported, Needham analyst Alex Henderson upgraded Finisar to Strong Buy from Buy as he expects a strong "beat and raise" quarter and strong results for 2017 and 2018. The analyst notes that strong demand for 10G/40G from Web 2.0 and sharply ramping 100G products should combine to deliver upside in the quarter and guide. He also raised his price target on the shares to $42 from $38.
11/28/16
NEED
11/28/16
UPGRADE
NEED
Strong Buy
Finisar upgraded to Strong Buy from Buy at Needham
11/28/16
PIPR
11/28/16
NO CHANGE
Target $38
PIPR
Overweight
Piper a buyer of Finisar ahead of December 8 results
Piper Jaffray analyst Troy Jensen recommends buying shares of Finisar ahead of the company's October quarter results on December 8. The analyst expects the results to be driven by robust demand for 100G Datacom and Telecom optics as well as better than expected demand for 40G datacom transceivers. Jensen views consensus estimates for the company's 2017 as "extremely conservative" and sees meaningful estimate revisions as the 100G upgrade cycle ramps throughout the year. The analyst reiterates an Overweight rating on Finisar with a $38 price target.
11/29/16
MKMP
11/29/16
NO CHANGE
MKMP
Finisar Q2 results likely to beat expectations, says MKM Partners
After conducting checks, MKM Partners analyst Michael Genovese expects Finisar's Q2 results to beat expectations, and he thinks that its revenue guidance will at least meet the consensus outlook. He raised his price target on the stock to $37.50 from $35 and reiterates a Buy rating.
LITE Lumentum
$40.10

-1.25 (-3.02%)

11/07/16
RAJA
11/07/16
UPGRADE
RAJA
Strong Buy
Lumentum upgraded to Strong Buy from Outperform at Raymond James
11/07/16
RAJA
11/07/16
UPGRADE
Target $45
RAJA
Lumentum upgraded to Strong Buy on valuation, positive data at Raymond James
As previously reported, Raymond James upgraded Lumentum to Strong Buy from Outperform and maintained its $45 price target. Analyst Simon Leopold changed his view following the recent pullback and said demand for optics in China remain solid and checks that indicate Lumentum will sees strong growth from both the QSFP28 used inside the data center and CFPx used to interconnect data centers.
10/31/16
NEED
10/31/16
NO CHANGE
NEED
Needham remains bullish on Optical Sector
Needham analyst Alex Henderson believes the "Optical Super Cycle" is going full steam ahead and strongly reiterates his bullish view on the Optical Sector. The analyst believes that most of the angst over the last week around the optical sector is a non-issue. Henderson is an aggressive buyer on weakness of Lumentum (LITE), NeoPhotonics (NPTN), Oclaro (OCLR), and Inphi (IPHI). Finisar (FNSR), Fabrinet (FN), II-VI (IIVI), GigPeak (GIG) and MACOM (MTSI) are also strong recommendations, he added. Further, Henderson believes Acacia Communications (ACIA) has "way overcorrected," and thinks it can rebound on a stronger Q4 outlook and upside to 2017 numbers.
11/07/16
WBLR
11/07/16
NO CHANGE
WBLR
Outperform
Facebook's Voyager a 'big win' for Acacia, says William Blair
William Blair analyst Dmitry Netis says Facebook's (FB) white-box packet optical transponder for data center interconnect applications, called Voyager, will incorporate Acacia Communications' (ACIA) AC400 transponder module, Broadcom's (AVGO) Tomahawk 25G Ethernet switch, an open line system with white boxes from Lumentum (LITE), as well as open software for end-to-end configuration from privately held SnapRoute. Facebook's Voyager will become a "disruptive force" in the optical networking market and represents a "major positive" for Acacia, Broadcom, and Lumentum, Netis tells investors in a research note. He views Facebook's announcement last week as confirming his belief that Acacia is poised to benefit disproportionately from white-box optics that enable leading Web 2.0 operators to build bespoke optical networks. The analyst reiterates an Outperform rating on Acacia.
OCLR Oclaro
$8.94

-0.2 (-2.19%)

11/02/16
NEED
11/02/16
NO CHANGE
Target $14
NEED
Strong Buy
Oclaro price target raised to $14 from $11 at Needham
Needham analyst Alex Henderson raised his price target for Oclaro to $14 from $11 following the company's Q1 results and after Oclaro visited the Chinese OEMs and Service Providers and concluded demand is "very robust and highly visible." Furthermore, the analyst believes this stock is "significantly undervalued" on the recent pull back in optical after the "strong" print. He reiterates a Strong Buy rating on the shares.
11/02/16
COWN
11/02/16
NO CHANGE
Target $13
COWN
Outperform
Oclaro price target raised to $13 from $9 at Cowen
Cowen analyst Paul Silverstein raised his price target on Oclaro to $13 from $9 following strong Q1 result and said he sees long-term growth and operating leverage ahead of his and Street estimates. The analyst also sees industry consolidation as providing a downside cushion. Silverstein reiterated his Outperform rating on Oclaro shares.
11/02/16
PIPR
11/02/16
NO CHANGE
Target $13
PIPR
Overweight
Oclaro price target raised to $13 from $9.50 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Oclaro to $13 citing the company's "outstanding" Q1 results. Revenue, margins and earnings all came in ahead of expectations, while Oclaro also guided Q2 sales "comfortably above consensus," Jensen tells investors in a post-earnings research note. He believes upside still exists to estimates from the 100G cycle and keeps an Overweight rating on the shares.
IPHI Inphi
$40.22

-4.95 (-10.96%)

11/02/16
ROTH
11/02/16
NO CHANGE
Target $50
ROTH
Buy
Inphi price target raised to $50 from $44 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Inphi to $50 from $44 after the company delivered a "strong" report. Now heading into 2017, Inphi looks to benefit from ColorZ, continued strong long-haul and metro demand in China, and the just announced acquisition of ClariPhy, Alger noted. The analyst reiterates a Buy rating on the shares.
10/14/16
COWN
10/14/16
INITIATION
Target $39
COWN
Market Perform
Inphi initiated with a Market Perform at Cowen
Cowen analyst Wayne Loeb initiated Inphi with a Market Perform rating and $39 price target. The analyst said PAM4 adoption in the data center and proprietary DCI adoption is coming, but somewhat later than expected.
11/29/16
JEFF
11/29/16
NO CHANGE
JEFF
Jefferies takes stance on semis to neutral from bullish
Jefferies analyst Mark Lipacis is taking his stance on the Semiconductors space to neutral from bullish following the Q3 earnings season. The earnings reports revealed two yellow flags, Lipacis tells investors in a research note. One, the companies have benefited from an inventory restock since Q2 and are forecasted to outship manufactures thru the first half of 2017, the analyst contends. And two, semi days of inventory has declined, historically a leading indicator of SOX peaks, Lipacis contends. He feels a more neutral stance on the sector is warranted and prefers product cycle stories NVIDIA (NVDA), AMD (AMD), MACOM (MTSI) and Inphi (IPHI).
MTSI MACOM
$49.82

0.32 (0.65%)

11/22/16
ADAM
11/22/16
DOWNGRADE
Target $8
ADAM
Hold
Applied Micro Circuits downgraded to Hold from Buy at Canaccord
Canaccord analyst Matthew Ramsay downgraded Applied Micro Circuits (AMCC) to Hold from Buy following the announcement it would be acquired by MACOM (MTSI) for $8.36 per share in cash and stock.
11/21/16
ROTH
11/21/16
DOWNGRADE
Target $8
ROTH
Neutral
Applied Micro Circuits downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Suji Desilva downgraded Applied Micro Circuits (AMCC) to Neutral from Buy, with an $8 price target, on the announcement of its planned stock plus cash acquisition by MACOM Technologies (MTSI). The analyst expects the acquisition to face limited anti-trust or regulatory issues given the lack of direct product market overlap, and believes MACOM will focus on the connectivity business and divest the Applied Micro Circuits compute business within approximately three months' timeframe.
AAOI Applied Optoelectronics
$24.77

-0.27 (-1.08%)

09/07/16
COWN
09/07/16
NO CHANGE
Target $28
COWN
Outperform
Applied Optoelectronics price target raised to $28 from $21 at Cowen
Cowen analyst Paul Silverstein raised his price target on Applied Optoelectronics to $28 from $21 after the company raised its guidance. The analyst said the company remains one of his top three picks and reiterated his Outperform rating on Applied Optoelectronics shares.
11/04/16
ROTH
11/04/16
NO CHANGE
Target $30
ROTH
Buy
Applied Optoelectronics price target raised to $30 from $23 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Applied Optoelectronics to $30 from $23 following an "impressive" beat and raise beyond pre-announced expectations. The analyst reiterates a Buy rating on the shares.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $23
ROTH
Buy
Applied Optoelectronics price target raised to $23 from $18.30 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Applied Optoelectronics to $23 from $18.30 after the company announced that it now expects to report "substantially better" results for the September quarter. The analyst reiterates a Buy rating on the shares.
10/05/16
PIPR
10/05/16
NO CHANGE
Target $27
PIPR
Overweight
Piper recommends exposure to optical component names
Piper Jaffray analyst Troy Jensen raised his estimates for all companies in his optical component coverage saying strength in optical demand will continue. Consensus estimates don't reflect the magnitude and sustainability of 100G cycle, Jensen tells investors in a research note. He recommends investors get exposure to the group. The analyst raised his price target for Applied Optoelectronics (AAOI) to $27 from $24, for Fabrinet (FN) to $53 from $50, for Finisar (FNSR) to $38 from $31, for Lumentum (LITE) to $47 from $38, for NeoPhotonics (NPTN) to $20 from $17 and for Oclaro (OCLR) to $10.50 from $9. Jensen has Overweight ratings on all six names.
CSCO Cisco
$29.82

-0.01 (-0.03%)

11/18/16
11/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cisco (CSCO) coverage resumed with a Hold at Stifel. 2. UPS (UPS) was initiated with an Outperform at BMO Capital while the firm initiated FedEx (FDX) with a Market Perform. 3. Synchrony (SYF) was initiated with an Overweight at Stephens. The firm also initiated American Express (AXP) and Discover (DFS) with an Underweight. 4. American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and Allegiant Travel (ALGT) were initiated with a Buy at Citi while the firm initiated JetBlue (JBLU), United Continental (UAL), Alaska Air (ALK), and Hawaiian Holdings (HA) with a Neutral. 5. Juniper (JNPR) coverage resumed at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/16
SBSH
11/22/16
NO CHANGE
Target $105
SBSH
Buy
Arista Networks price target raised to $105 from $91 at Citi
Citi analyst Stanley Kovler raised his price target for Arista Networks (ANET) to $105 after the company announced that the International Trade Commission accepted its software workaround related to its patent infringement case with Cisco (CSCO). Arista's Q4 gross margin outlook is now likely de-risked, Kovler tells investors in a research note. He keeps a Buy rating on Arista shares.
11/22/16
PIPR
11/22/16
NO CHANGE
Target $178
PIPR
Overweight
Palo Alto Networks still posting 31% revenue growth, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski points out that despite the "disappointing" Q1 results, Palo Alto Networks (PANW) is still generating 31% revenue growth, which is three-times above closest competitor Cisco (CSCO). He recommends investors hold the stock through the selling pressure. Nowinski lowered his price target for Palo Alto shares to $178 from $184 and keeps an Overweight rating on the name.
11/23/16
OPCO
11/23/16
NO CHANGE
Target $25
OPCO
Outperform
Oppenheimer remains positive on HP Enterprise after results
Oppenheimer analyst Ittai Kidron notes that HP Enterprise (HPE) reported mixed results and says the macro and secular strains experienced by Cisco (CSCO) seem to have impacted the company as well. Nonetheless, the analyst believes HP Enterprise continues on its march to unlock value, and its two spin-offs remain on track. While he is positive long term and believes valuation is attractive, Kidron sees limited near-term upside given the challenges in the core EG business. The analyst reiterates an Outperform rating and $25 price target on HP Enterprise's shares.
JNPR Juniper
$26.92

-0.62 (-2.25%)

11/16/16
GSCO
11/16/16
UPGRADE
Target $31
GSCO
Conviction Buy
Juniper upgraded to Conviction Buy from Buy at Goldman
Goldman analyst Simona Jankowski added Juniper to the Conviction Buy List saying she expects new switching products to drive top and bottom-line growth in 2017 and views valuation as attractive. Jankowski is almost $100M, or 10% ahead of consensus on her Switching sales saying there has already been a significant acceleration of deferred product revenues. The analyst has a $31 price target on Juniper shares.
11/16/16
11/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Buy from Hold at Deutsche Bank with analyst Bryan Kraft citing increased confidence in the company's outlook for 2017. 2. Fitbit upgraded to Sector Weight from Underweight at Pacific Crest with analyst Brad Erickson citing valuation. 3. Copa Holdings (CPA) upgraded to Buy from Neutral at Goldman with analyst Marcio Prado saying Copa is well positioned for an expected recovery cycle given more rationalized sector capacity and improved yields, and structural advantages. 4. Fossil upgraded to Overweight from Underweight at Pacific Crest with analyst Edward Yruma saying he expects the company to benefit from continuing "strong momentum in wearables." 5. Juniper (JNPR) upgraded to Conviction Buy from Buy at Goldman with analyst Simona Jankowski saying she expects new switching products to drive top and bottom-line growth in 2017 and views valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
STFL
11/18/16
INITIATION
STFL
Buy
Juniper coverage resumed at Stifel
As noted earlier, Stifel resumed coverage of Juniper with a Buy rating. Analyst Aaron Rakers is upbeat on the company's new products and finds its valuation attractive. Target $33.
AVGO Broadcom
$170.49

-4.96 (-2.83%)

11/07/16
RBCM
11/07/16
NO CHANGE
RBCM
Microsemi price target raised to $56 from $48 at RBC Capital
After Bloomberg reported that Microsemi (MSCC) was looking to sell itself, RBC Capital analyst Mitch Steves says that Microsemi could be attractive to many potential acquirers. He names Skyworks (SWKS), Texas Instruments (TXN), Maxim (MXIM) and Broadcom (AVGO) as potential acquirers of Microsemi. However, the analyst thinks that it "may be a bit to early for a deal." Nonetheless, he raised his price target on the name to $56 from $48 and keeps a Top Pick rating on the shares.
11/29/16
RBCM
11/29/16
NO CHANGE
RBCM
Broadcom Q4 EPS likely to beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani believes that Broadcom's Q4 EPS will beat expectations by a "sizable" amount." The analyst also expects the company to raise its dividend by 50%-100%. He says that the EPS beat will be driven by margin increases which "reflect revenue synergies and cost take-out benefits." The analyst expects the company's EPS to rise by around 15% over the next several years. He keeps a $190 price target and a Top Pick rating on the shares.
11/03/16
UBSW
11/03/16
NO CHANGE
Target $205
UBSW
Buy
Broadcom acquisition of Brocade 10% accretive in 2018, says UBS
UBS analyst Stephen Chin estimates a 10% accretion to earnings in 2018 for Broadcom (BRCM) from its acquisition of Brocade (BRCD). The analyst lays out potential challenges for the deal, including the cost reductions necessary for accretion, integration of its service model, divesting network assets, and a regulatory review of the combined market share. Chin reiterated his Buy rating and $205 price target on Broadcom shares.
MRVL Marvell
$14.34

-0.04 (-0.28%)

11/03/16
BMUR
11/03/16
NO CHANGE
Target $16
BMUR
Buy
Marvell operating expense cuts impressive, says Brean Capital
Brean Capital analyst Mike Burton said he is impressed with Marvell's follow through on its plans to drive returns to patient shareholders by cutting operating expenses. The analyst added the stock to the firm's top pick list as he believes they are a good "special situation" for investors as the company re-aligns its margin profile. Burton reiterated his Buy rating and raised his price target to $16 from $15 on Marvell shares.
11/22/16
RHCO
11/22/16
NO CHANGE
RHCO
Microsemi could be acquired for $70-$90 per share, says SunTrust
After press reports suggested that Microsemi (MSCC) could be acquired by Skyworks (SWKS), SunTrust analyst William Stein estimates, based on past semiconductor deals, that Microsemi could be acquired for $70-$90 per share. The analyst thinks that Infineon (IFNNY), Marvell (MRVL), and STMicroelectronics (STM) could also be interested in acquiring Microsemi. The analyst keeps a $58 price target and a Buy rating on Microsemi.
11/18/16
SUSQ
11/18/16
UPGRADE
Target $17
SUSQ
Positive
Marvell upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Christopher Rolland upgraded Marvell to Positive form Neutral. In a previous note, the analyst called Marvell his top takeout candidate. Rolland feels the company could make a few adjustments to its business to unlock additional earnings power and now sees a $17 takeout price as achievable.
11/18/16
SUSQ
11/18/16
UPGRADE
SUSQ
Positive
Marvell upgraded to Positive from Neutral at Susquehanna
CAVM Cavium
$57.03

-0.28 (-0.49%)

11/21/16
JEFF
11/21/16
DOWNGRADE
Target $37
JEFF
Underperform
Mellanox downgraded to Underperform from Hold at Jefferies
Jefferies analyst James Kisner downgraded Mellanox Technologies (MLNX) to Underperform after performing channel checks at a recent trade show. Intel's (INTC) launch of Skylake in the first half of 2017 and possible share loss to Cavium (CAVM) follow its acquisition of QLogic could create "significant incremental pressure" on Mellanox's InfiniBand business, Kisner tells investors in a research note. He cut his price target for the shares to $37 from $42.
11/02/16
BMUR
11/02/16
NO CHANGE
Target $63
BMUR
Buy
Cavium price target raised to $63 from $57 at Brean Capital
Brean Capital analyst Mike Burton raised his price target on Cavium to $63 from $57 following its Q3 results. The analyst cited its strong product cycles in combination with solid results from newly acquired Qlogic. Burton believes the combination of the two companies will result in one of the few Communications and Data Center semiconductor pure plays in the market. Burton reiterated his Buy rating on Cavium shares.
09/20/16
SUSQ
09/20/16
INITIATION
Target $65
SUSQ
Positive
Cavium initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Cavium with a Positive and a $65 price target given new product offerings that address the massive greenfield markets.
10/31/16
ROTH
10/31/16
NO CHANGE
Target $65
ROTH
Buy
Cavium price target raised to $65 from $59 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Cavium to $65 from $59 as he believes it is regaining its stride as a leading growth company. Further, the analyst thinks the September quarter saw "strong" end market demand for Cavium's solutions. He reiterates a Buy rating on the shares.
MLNX Mellanox
$41.45

0.45 (1.10%)

10/28/16
BMUR
10/28/16
NO CHANGE
Target $52
BMUR
Buy
Mellanox price target lowered to $52 from $60 at Brean Capital
Brean Capital analyst Mike Burton lowered his price target on Mellanox to $52 from $60 following Q3 results. The company issued disappointing guidance but the analyst remains constructive on the shares and the company's prospects as he believes the company is well positioned in both its Ethernet business and its core InfinBand business. Burton maintained his Buy rating on Mellanox shares.
10/28/16
ROTH
10/28/16
NO CHANGE
Target $60
ROTH
Buy
Mellanox price target lowered to $60 from $70 at Roth Capital
Roth Capital analyst Brian Alger lowered his price target for Mellanox to $60 from $70 following the company's in-line Q3 results that were overshadowed by soft Ethernet guidance. While the analyst expects the market to negatively react to the reduced near term outlook, he believes Mellanox's strategic positioning, relatively low valuation, and consistent cash flow warrant continued investment. Alger reiterates a Buy rating on the shares.
10/19/16
STFL
10/19/16
NO CHANGE
STFL
Mellanox has positive read through from Intel results, says Stifel
Stifel analyst Kevin Cassidy says that the 32% growth of Intel's (INTC) revenue from Cloud Service providers last quarter bodes well for Mellanox (MLNX). The analyst estimates that Mellanox has roughly 32% revenue exposure to this market segment. He keeps an $85 price target and Buy rating on the shares.

TODAY'S FREE FLY STORIES

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDEX

PRO-DEX

$4.48

0.034 (0.76%)

17:06
12/09/16
12/09
17:06
12/09/16
17:06
Syndicate
Breaking Syndicate news story on PRO-DEX »

PRO-DEX files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFBX

Peoples Financial

$14.50

-0.5 (-3.33%)

17:02
12/09/16
12/09
17:02
12/09/16
17:02
Hot Stocks
Breaking Hot Stocks news story on Peoples Financial »

Jeffrey L. Gendell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUIK

QuickLogic

$0.94

-0.0163 (-1.71%)

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Syndicate
Breaking Syndicate news story on QuickLogic »

QuickLogic files $40M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRZA

Starz

17:00
12/09/16
12/09
17:00
12/09/16
17:00
Hot Stocks
Breaking Hot Stocks news story on Starz »

Elliott Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEL

Belmond

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Syndicate
Breaking Syndicate news story on Belmond »

Belmond files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

16:55
12/09/16
12/09
16:55
12/09/16
16:55
Hot Stocks
Breaking Hot Stocks news story on Parnell »

Parnell trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$43.73

0.15 (0.34%)

, SHAK

Shake Shack

$38.08

0.82 (2.20%)

16:50
12/09/16
12/09
16:50
12/09/16
16:50
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Shake Shack »

Morgan Stanley reports…

MS

Morgan Stanley

$43.73

0.15 (0.34%)

SHAK

Shake Shack

$38.08

0.82 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.